These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 19831387)

  • 1. Three-dimensional pharmacophore methods in drug discovery.
    Leach AR; Gillet VJ; Lewis RA; Taylor R
    J Med Chem; 2010 Jan; 53(2):539-58. PubMed ID: 19831387
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharao: pharmacophore alignment and optimization.
    Taminau J; Thijs G; De Winter H
    J Mol Graph Model; 2008 Sep; 27(2):161-9. PubMed ID: 18485770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecule-pharmacophore superpositioning and pattern matching in computational drug design.
    Wolber G; Seidel T; Bendix F; Langer T
    Drug Discov Today; 2008 Jan; 13(1-2):23-9. PubMed ID: 18190860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2007.
    Dolle RE; Le Bourdonnec B; Goodman AJ; Morales GA; Thomas CJ; Zhang W
    J Comb Chem; 2008; 10(6):753-802. PubMed ID: 18991466
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches.
    Eckert H; Bajorath J
    Drug Discov Today; 2007 Mar; 12(5-6):225-33. PubMed ID: 17331887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A self-organizing algorithm for molecular alignment and pharmacophore development.
    Bandyopadhyay D; Agrafiotis DK
    J Comput Chem; 2008 Apr; 29(6):965-82. PubMed ID: 17999384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques.
    Wei HY; Lu CS; Lin TH
    J Mol Graph Model; 2008 Apr; 26(7):1131-44. PubMed ID: 18024210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening.
    Klabunde T; Giegerich C; Evers A
    J Med Chem; 2009 May; 52(9):2923-32. PubMed ID: 19374402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship study of antimalarial indolo [2,1-b]quinazoline-6,12-diones (tryptanthrins). Three dimensional pharmacophore modeling and identification of new antimalarial candidates.
    Bhattacharjee AK; Hartell MG; Nichols DA; Hicks RP; Stanton B; van Hamont JE; Milhous WK
    Eur J Med Chem; 2004 Jan; 39(1):59-67. PubMed ID: 14987834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of AMANDA, a new algorithm for selecting highly relevant regions in Molecular Interaction Fields.
    Durán A; Martínez GC; Pastor M
    J Chem Inf Model; 2008 Sep; 48(9):1813-23. PubMed ID: 18693718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atomic property fields: generalized 3D pharmacophoric potential for automated ligand superposition, pharmacophore elucidation and 3D QSAR.
    Totrov M
    Chem Biol Drug Des; 2008 Jan; 71(1):15-27. PubMed ID: 18069986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of drug-target residence time.
    Zhang R; Monsma F
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):488-96. PubMed ID: 19562645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining pharmacophore fingerprints and PLS-discriminant analysis for virtual screening and SAR elucidation.
    Askjaer S; Langgård M
    J Chem Inf Model; 2008 Mar; 48(3):476-88. PubMed ID: 18281962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smaller is better for antibiotic discovery.
    Waldrop GL
    ACS Chem Biol; 2009 Jun; 4(6):397-9. PubMed ID: 19537754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiobjective optimization of pharmacophore hypotheses: bias toward low-energy conformations.
    Gardiner EJ; Cosgrove DA; Taylor R; Gillet VJ
    J Chem Inf Model; 2009 Dec; 49(12):2761-73. PubMed ID: 19908873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting druggable binding sites at the protein-protein interface.
    Fuller JC; Burgoyne NJ; Jackson RM
    Drug Discov Today; 2009 Feb; 14(3-4):155-61. PubMed ID: 19041415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based approaches to antibiotic drug discovery.
    Nicola G; Abagyan R
    Curr Protoc Microbiol; 2009 Feb; Chapter 17():Unit17.2. PubMed ID: 19235149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional solution structure of EM703 with potent promoting activity of monocyte-to-macrophage differentiation.
    Gouda H; Sunazuka T; Yoshida K; Sugawara A; Sakoh Y; Omura S; Hirono S
    Bioorg Med Chem Lett; 2006 May; 16(9):2496-9. PubMed ID: 16480872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analogs of methyllycaconitine as novel noncompetitive inhibitors of nicotinic receptors: pharmacological characterization, computational modeling, and pharmacophore development.
    McKay DB; Chang C; González-Cestari TF; McKay SB; El-Hajj RA; Bryant DL; Zhu MX; Swaan PW; Arason KM; Pulipaka AB; Orac CM; Bergmeier SC
    Mol Pharmacol; 2007 May; 71(5):1288-97. PubMed ID: 17308033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SitePrint: three-dimensional pharmacophore descriptors derived from protein binding sites for family based active site analysis, classification, and drug design.
    Arnold JR; Burdick KW; Pegg SC; Toba S; Lamb ML; Kuntz ID
    J Chem Inf Comput Sci; 2004; 44(6):2190-8. PubMed ID: 15554689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.